Home / People / Jane Evenson
Portrait ofJane Evenson

Jane Evenson

Partner
Patent Attorney

Contact
CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
London
EC4N 6AF
United Kingdom
Languages English

Jane is a Partner, UK Chartered Patent Attorney and European Patent Attorney with over 20 years of experience working in the life sciences and chemistry field. She is mentioned as a key lawyer in the CMS Tier 1 ranked team in the Legal 500 2022 directory and is a recommended lawyer in the IAM Patent 1000 2022 directory. 

Jane’s practice focuses on written and oral representation before the European Patent Office (EPO) in examination and opposition proceedings at first instance and at appeal. Through careful analysis, creative thinking and skilful advocacy, Jane has an excellent track record in offensive and defensive oppositions and in finding solutions for taking EP patent applications to grant where the examiner’s view has become entrenched. She has been praised for her meticulous, evidence-based, and concise approach. 

Jane has particular expertise in peptide and protein-based technologies including therapeutic and diagnostic antibodies and antibody conjugates, fusion proteins, CAR-T cells, cytokines, and biomarkers; antisense oligonucleotides; small molecules; siRNA; diagnostic assays; PCR and amplification reaction technology; viruses and AAV vector technology; and formulation inventions.

Jane is qualified to act before the Unified Patent Court. She also sits on the UK CIPA life sciences committee and, for many years, she was an examiner for the UK patent attorney finals level qualifying exams.

more less

"Knowledgeable, and diligent in her work. Her counsel is sound and her work at the EPO on our behalf is of great quality. An invaluable resource in our work at the EPO."

Juve Directory 2024

"Jane Evenson is extremely knowledgeable and up to date on patent law, and provides detailed, thoughtful and meaningful advice and strategy on European patent applications."

IAM Patent 1000, 2023

"Jane is attuned to the importance of alerting clients to European legal intricacies that they might not have appreciated. She explains rules and regulations clearly, and seeks to be an extension of in-house capabilities."

IAM Patent 1000, 2023

"Jane provides guidance that makes sense and delivers stronger patents."

IAM Patent 1000, 2023

Jane "has worked hard to build a reputation for her EPO oppositions work over her 20 years in practice, but is also known for strategic prosecution: She not only understands the law, but she is quick to grasp technology and she always keeps in perspective how this case is connected with the client’s business. She provides pragmatic advice balancing the risks and business needs".

IAM Patent 1000, 2022

Life sciences ace Jane Evenson “comes up to speed quickly and thoroughly on the technology, and can always be counted on to be prepared and offer insightful, commercially relevant guidance”.

IAM Patent 1000, 2021

"The arrival of [key lawyer] Jane Evenson and her team bolsters [CMS] bench in life sciences, especially in antibody patent work." Tier 1: PATMA Patent Attorney.

Legal 500 UK 2021

Named as a “key lawyer”, the “arrival of Jane Evenson.. and her team bolsters [CMS] bench in the life sciences, especially in antibody patent work.

UK Legal 500 PATMA: Patent Attorneys, 2020

Memberships & Roles

  • Member, CIPA’s Life Sciences Committee.
  • The Antibody Society.
more less

Education

  • 1996 – BSc Chemistry, Durham University, Durham
more less

Feed

06/10/2023
The European Patent Office (EPO) ‘10-day rule’
By the Decision of the Administrative Council of 13 October 2022, a number of Rules of the Implementing Regulations to the European Patent Convention have been amended. These include Rule 126 (Notification...
10/07/2023
New referral to the EPO Enlarged Board of Appeal – G 1/23 ("solar cell")
On 29 June 2023, the European Patent Office announced that the Technical Board of Appeal 3.3.03 has by interlocutory decision T 438/19 referred three questions to the Enlarged Board of Appeal. The referral...
23/03/2023
European Patent Office (EPO) digging its heals in over the need for description...
As a complement to the 10th edition of the EPO "Case Law of the Boards of Appeal" (CLB), the EPO has published an Annual Review containing summaries of decisions from 2022. The review provides a thematic...
22/03/2023
European Patent Office (EPO) level of disclosure required for antibodies...
As a complement to the 10th edition of the EPO "Case Law of the Boards of Appeal" (CLB), the EPO has published an Annual Review containing summaries of decisions from 2022. The review provides a thematic...
21/02/2023
Unified Patent Court (UPC) News: countdown begins 17 February 2023
The UPC website has reported that Germany has deposited its ratification of the UPC Agreement, starting the formal countdown process to the initiation of the sunrise period on 1 March (for opting out...
06/02/2023
European Patent Office News - Oral proceedings by videoconference before...
In the light of the developments in the coronavirus (COVID-19) pandemic, the EPO has announced that the Boards of Appeal will lift measures regulating the arrangement and conduct of oral proceedings from...
06/02/2023
European Patent Office News - EPO’s appeal system provides independent...
The Second Senate of the Federal Constitutional Court has rejected as inadmissible several constitutional appeals by which the appellants challenged decisions of the Technical Boards of Appeal and the...
23/11/2022
EPO President decides future format of oral proceedings in opposition
As the pilot project for oral proceedings in opposition by video conference (VICO) draws to a close, the EPO President has carefully evaluated its conclusions as well as the feedback from the numerous...
15/11/2022
EPO sets start of UP and UPC related transitional measures to 1 January...
Aligning with the recently published implementation roadmap published by the Unified Patent Court (UPC), the EPO has decided to adjust the starting date of its transitional measures to 1 January 2023...
05/04/2022
Recent updates to the EPO Guidelines for Examination relevant to inventions...
An amended version of the EPO Guidelines for Examination entered into force on 1 March 2022, superseding the edition of March 2021. Here we review the updates relevant to inventions in the field of biotechnology...
01/02/2022
UPC: Is it finally here?
New temporary provisions at the European Patent Office relating to the Unitary Patent The European Patent Office (EPO) issued 3 new notices on 19 January 2022 about the Unitary Patent. They are: Decision...
10/11/2021
COVID and ViCo: The End?
Enlarged Board of Appeal decision G1/21 Background Following an EPO press release on 16 July 2021, the Enlarged Board of Appeal’s (EBA) decision on video­con­fer­en­cing (ViCo) was released last week. We...